首页> 外国专利> Pharmaceutical composition for inhibiting angiogenesis comprising bioconversion of Orostachys Japonicus extracts

Pharmaceutical composition for inhibiting angiogenesis comprising bioconversion of Orostachys Japonicus extracts

机译:包括日本牛膝提取物的生物转化的抑制血管生成的药物组合物

摘要

The present invention relates to a composition for inhibiting angiogenesis and the like comprising a bioconverted Wasong extract as an active ingredient, and the composition according to the present invention inhibits the ability to move and adhere to vascular endothelial cells, and has excellent activity to inhibit angiogenesis. Thus, there is an effect that can be usefully used as a therapeutic agent for various diseases including cancer in which angiogenesis is abnormally controlled. In particular, the existing compounds having angiogenesis inhibitory activity had severe side effects, but the angiogenesis inhibitory composition according to the present invention uses natural products extracted from plants, and has no side effects and has excellent medicinal efficacy, so it is more excellent angiogenesis inhibitor. It is expected to be used as
机译:本发明涉及包含生物转化的瓦松提取物作为活性成分的抑制血管生成等的组合物,并且根据本发明的组合物抑制移动并粘附于血管内皮细胞的能力,并且具有优异的抑制血管生成的活性。 。因此,具有可以有效地用作包括血管生成被异常控制的癌症在内的各种疾病的治疗剂的作用。特别地,现有的具有血管生成抑制活性的化合物具有严重的副作用,但是根据本发明的血管生成抑制组合物使用从植物中提取的天然产物,并且没有副作用并且具有优异的药效,因此它是更优异的血管生成抑制剂。 。预计将用作

著录项

  • 公开/公告号KR102168791B1

    专利类型

  • 公开/公告日2020-10-22

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR1020170157559

  • 申请日2017-11-23

  • 分类号A61K36/41;A23L33/105;

  • 国家 KR

  • 入库时间 2022-08-21 11:03:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号